• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Promising Advances in Fatty Liver Disease Treatment with Semaglutide

Raja Aditya by Raja Aditya
2 years ago
in Healthcare & Medicine, Science News
0
Semaglutide

Promising Advances in Fatty Liver Disease Treatment with Semaglutide | Neo Science Hub

Recent clinical trials have highlighted the potential of semaglutide, a GLP-1 receptor agonist, in treating Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD), previously known as Non-Alcoholic Fatty Liver Disease (NAFLD). The findings from a phase 3 trial published in the New England Journal of Medicine reveal compelling results regarding weight loss and the associated improvements in liver health for participants treated with semaglutide.

Key Findings from the Trial

The phase 3 trial involved participants receiving weekly semaglutide injections for one and a half years. The results were striking:

– Approximately 62.9% of individuals treated with semaglutide experienced a decrease in liver fat and inflammation, compared to just 34.3% in the placebo group.

– Liver stiffness, an indicator of fibrosis, decreased in 36.8% of subjects receiving semaglutide, versus 22.4% among those who were not treated.

– On average, participants lost about 10% of their body weight during the trial.

This data supports current medical understandings that suggest significant weight loss can lead to improvements in liver conditions, including reductions in liver fat and fibrosis.

Understanding MAFLD

MAFLD is characterized by excessive fat accumulation in the liver, which can lead to inflammation, scarring, and even progression to liver cancer. The condition is becoming increasingly common worldwide, with prevalence rates varying between 9% and 32% in different populations, such as in India. The rising obesity rates and sedentary lifestyles are often contributors to this disorder.

Mechanism of Action of Semaglutide

Semaglutide operates by mimicking the function of certain gut hormones. It enhances insulin secretion, suppresses glucagon secretion (a hormone that increases glucose production in the liver), and reduces appetite by slowing digestion. These actions not only support weight loss but also contribute to improving liver function in patients with MAFLD.

While weight loss contributes significantly to the observed benefits, it remains unclear how much of the liver improvement can be attributed directly to semaglutide, as weight loss alone can lead to comparable effects.

Current and Emerging Treatments

The primary approach to managing MAFLD remains weight loss, which can be achieved through lifestyle modifications or pharmacological interventions. In addition to semaglutide, there are other treatment options being explored:

1. Resmetirom: Targeting thyroid hormones, offering another avenue for patients struggling with weight loss.

2. FGF21 medications: These work on adipose tissues to promote weight loss.

However, these treatments are often associated with side effects, including nausea and riskier complications, making careful diagnosis and management essential.

The recent findings on semaglutide signify a promising advancement in the treatment of MAFLD. As further research unfolds, there is potential not only to improve individual health outcomes but also to address a significant public health challenge. This evolving landscape in the treatment of fatty liver disease underscores the importance of ongoing clinical trials, patient education on lifestyle changes, and the role of medication in comprehensive management strategies.

-Raja Aditya

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: featuredMetabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD)Non-Alcoholic Fatty Liver Disease (NAFLD)sciencenewssemaglutide
Raja Aditya

Raja Aditya

Associate Editor for Neo Science Hub Magazine

Other Posts

Young maize in paired rows on raised beds with water in the furrows between them

Lifting the Crop Off the Floor: Why Raised Beds Are Gaining Ground in a Water-Short Country

November 15, 2026 - Updated on November 16, 2026
5
Trays of green and purple microgreens beside a field being sprayed

Small Leaves, Small Particles: Microgreens Have the Evidence. Nano-Urea Is Still Earning It

November 15, 2026 - Updated on November 16, 2026
4

A Crore and a Half Recharge Pits Later: What India’s Water Reforms Can, and Cannot, Teach the Global South

A Purple Broccoli That Seeds in Delhi and a Sponge Gourd That Shrugs Off a Virus

Fourteen Seconds to 241 km/h and Back: What a Runway Test Says About Where Car Performance Now Lives

An Aeroplane on a Helipad: What Electra’s Manhattan Landing Proves, and What It Does Not

After the Space Station: NASA Opens the Contest to Become a Tenant in Orbit

At 94, the Air Force Counts Its Squadrons, and Waits for an Engine India Can Call Its Own

Next Post
Leopards prefer to hunt in the night when there is no threat from bigger cats like the Tiger or Lions or even humans in the natural jungles of India.[ Photo CopyRight N.Shiva Kumar]

Leopards The Last Shadows Between Us and Ecological Collapse

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
8

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist